Mostrar el registro sencillo del ítem

dc.contributor.author
Gonzalez, Patricia Verónica  
dc.contributor.author
Machado, Ivana Noelia  
dc.contributor.author
Vilcaes, Aldo Alejandro  
dc.contributor.author
Caruso, Carla Mariana  
dc.contributor.author
Roth, German Alfredo  
dc.contributor.author
Schiöth, H.  
dc.contributor.author
Lasaga, Mercedes Isabel  
dc.contributor.author
Scimonelli, Teresa Nieves  
dc.date.available
2017-04-10T20:47:54Z  
dc.date.issued
2013-10  
dc.identifier.citation
Gonzalez, Patricia Verónica; Machado, Ivana Noelia; Vilcaes, Aldo Alejandro; Caruso, Carla Mariana; Roth, German Alfredo; et al.; Molecular mechanisms involved in interleukin 1-beta (IL-1b)-induced memory impairment. Modulation by alpha-melanocyte-stimulating hormone (a-MSH); Elsevier; Brain Behavior And Immunity; 34; 10-2013; 141-150  
dc.identifier.issn
0889-1591  
dc.identifier.uri
http://hdl.handle.net/11336/15109  
dc.description.abstract
Pro-inflammatory cytokines can affect cognitive processes such as learning and memory. Particularly, interleukin-1β (IL-1β) influences the consolidation of hippocampus-dependent memories. We previously reported that administration of IL-1β in dorsal hippocampus impaired contextual fear memory consolidation. Different mechanisms have been implicated in the action of IL-1β on long-term potentiation (LTP), but the processes by which this inhibition occurs in vivo remain to be elucidated. We herein report that intrahippocampal injection of IL-1β induced a significant increase in p38 phosphorylation after contextual fear conditioning. Also, treatment with SB203580, an inhibitor of p38, reversed impairment induced by IL-1β on conditioned fear behavior, indicating that this MAPK would be involved in the effect of the cytokine. We also showed that IL-1β administration produced a decrease in glutamate release from dorsal hippocampus synaptosomes and that treatment with SB203580 partially reversed this effect. Our results indicated that IL-1β-induced impairment in memory consolidation could be mediated by a decrease in glutamate release. This hypothesis is sustained by the fact that treatment with d-cycloserine (DCS), a partial agonist of the NMDA receptor, reversed the effect of IL-1β on contextual fear memory. Furthermore, we demonstrated that IL-1β produced a temporal delay in ERK phosphorylation and that DCS administration reversed this effect. We also observed that intrahippocampal injection of IL-1β decreased BDNF expression after contextual fear conditioning. We previously demonstrated that α-MSH reversed the detrimental effect of IL-1β on memory consolidation. The present results demonstrate that α-MSH administration did not modify the decrease in glutamate release induced by IL-1β. However, intrahippocampal injection of α-MSH prevented the effect on ERK phosphorylation and BDNF expression induced by IL-1β after contextual fear conditioning. Therefore, in the present study we determine possible molecular mechanisms involved in the impairment induced by IL-1β on fear memory consolidation. We also established how this effect could be modulated by α-MSH.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/  
dc.subject
Il-1beta  
dc.subject
Memory Consolidation  
dc.subject
Alpha-Msh  
dc.subject
Glutamate Release  
dc.subject
P38  
dc.subject
Erk  
dc.subject
Bdnf  
dc.subject.classification
Neurociencias  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Molecular mechanisms involved in interleukin 1-beta (IL-1b)-induced memory impairment. Modulation by alpha-melanocyte-stimulating hormone (a-MSH)  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2017-04-07T15:17:44Z  
dc.journal.volume
34  
dc.journal.pagination
141-150  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Amsterdam  
dc.description.fil
Fil: Gonzalez, Patricia Verónica. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Instituto de Farmacología Experimental de Córdoba; Argentina  
dc.description.fil
Fil: Machado, Ivana Noelia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Instituto de Farmacología Experimental de Córdoba; Argentina  
dc.description.fil
Fil: Vilcaes, Aldo Alejandro. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones En Química Biológica de Córdoba (p); Argentina; Argentina  
dc.description.fil
Fil: Caruso, Carla Mariana. Consejo Nacional de Investigaciones Cientificas y Tecnicas. Oficina de Coordinacion Administrativa Houssay. Instituto de Investigaciones Biomedicas; Argentina; Argentina  
dc.description.fil
Fil: Roth, German Alfredo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones En Química Biológica de Córdoba (p); Argentina; Argentina  
dc.description.fil
Fil: Schiöth, H.. Uppsala University; Suecia  
dc.description.fil
Fil: Lasaga, Mercedes Isabel. Consejo Nacional de Investigaciones Cientificas y Tecnicas. Oficina de Coordinacion Administrativa Houssay. Instituto de Investigaciones Biomedicas; Argentina; Argentina  
dc.description.fil
Fil: Scimonelli, Teresa Nieves. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Instituto de Farmacología Experimental de Córdoba; Argentina  
dc.journal.title
Brain Behavior And Immunity  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0889159113004182  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.bbi.2013.08.007